Long non-coding RNAs drive metastatic progression in melanoma (review)

Pouria Akhbari, Adrian Whitehouse, James R. Boyne

Research output: Contribution to journalReview article

9 Citations (Scopus)

Abstract

Metastatic melanoma is the leading cause of skin-cancer related deaths and while in recent years some progress has been made with targeted therapies, there remains an urgent unmet need for novel therapeutic treatments and reliable diagnostic, prognostic and predictive biomarkers. The emergence of next generation sequencing (NG S) has seen a growing appreciation for the role played by non-coding genomic transcripts in regulating gene expression and by extension impacting on disease progression. The long non-coding RNA s (lncRNA s) represent the most enigmatic of these new regulatory molecules. Our understanding of how lncRNA s regulate biological functions and their importance to disease aetiology, while still limited, is rapidly improving, in particular with regards to their role in cancer. Herein we review the identification of several lncRNAs shown to impact on melanoma disease progression and discuss how these molecules are operating at the molecular level.

Original languageEnglish
Pages (from-to)2181-2186
Number of pages6
JournalInternational Journal of Oncology
Volume45
Issue number6
DOIs
Publication statusPublished - Dec 2014
Externally publishedYes

Fingerprint

Long Noncoding RNA
Melanoma
Disease Progression
Skin Neoplasms
Biomarkers
Gene Expression
Therapeutics
Neoplasms

Cite this

Akhbari, Pouria ; Whitehouse, Adrian ; Boyne, James R. / Long non-coding RNAs drive metastatic progression in melanoma (review). In: International Journal of Oncology. 2014 ; Vol. 45, No. 6. pp. 2181-2186.
@article{52a098a641894a9aaf45bb7f9c564056,
title = "Long non-coding RNAs drive metastatic progression in melanoma (review)",
abstract = "Metastatic melanoma is the leading cause of skin-cancer related deaths and while in recent years some progress has been made with targeted therapies, there remains an urgent unmet need for novel therapeutic treatments and reliable diagnostic, prognostic and predictive biomarkers. The emergence of next generation sequencing (NG S) has seen a growing appreciation for the role played by non-coding genomic transcripts in regulating gene expression and by extension impacting on disease progression. The long non-coding RNA s (lncRNA s) represent the most enigmatic of these new regulatory molecules. Our understanding of how lncRNA s regulate biological functions and their importance to disease aetiology, while still limited, is rapidly improving, in particular with regards to their role in cancer. Herein we review the identification of several lncRNAs shown to impact on melanoma disease progression and discuss how these molecules are operating at the molecular level.",
keywords = "Long non-coding RNA, Melanoma, Metastasis",
author = "Pouria Akhbari and Adrian Whitehouse and Boyne, {James R.}",
year = "2014",
month = "12",
doi = "10.3892/ijo.2014.2691",
language = "English",
volume = "45",
pages = "2181--2186",
journal = "International Journal of Oncology",
issn = "1019-6439",
publisher = "Spandidos Publications",
number = "6",

}

Long non-coding RNAs drive metastatic progression in melanoma (review). / Akhbari, Pouria; Whitehouse, Adrian; Boyne, James R.

In: International Journal of Oncology, Vol. 45, No. 6, 12.2014, p. 2181-2186.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Long non-coding RNAs drive metastatic progression in melanoma (review)

AU - Akhbari, Pouria

AU - Whitehouse, Adrian

AU - Boyne, James R.

PY - 2014/12

Y1 - 2014/12

N2 - Metastatic melanoma is the leading cause of skin-cancer related deaths and while in recent years some progress has been made with targeted therapies, there remains an urgent unmet need for novel therapeutic treatments and reliable diagnostic, prognostic and predictive biomarkers. The emergence of next generation sequencing (NG S) has seen a growing appreciation for the role played by non-coding genomic transcripts in regulating gene expression and by extension impacting on disease progression. The long non-coding RNA s (lncRNA s) represent the most enigmatic of these new regulatory molecules. Our understanding of how lncRNA s regulate biological functions and their importance to disease aetiology, while still limited, is rapidly improving, in particular with regards to their role in cancer. Herein we review the identification of several lncRNAs shown to impact on melanoma disease progression and discuss how these molecules are operating at the molecular level.

AB - Metastatic melanoma is the leading cause of skin-cancer related deaths and while in recent years some progress has been made with targeted therapies, there remains an urgent unmet need for novel therapeutic treatments and reliable diagnostic, prognostic and predictive biomarkers. The emergence of next generation sequencing (NG S) has seen a growing appreciation for the role played by non-coding genomic transcripts in regulating gene expression and by extension impacting on disease progression. The long non-coding RNA s (lncRNA s) represent the most enigmatic of these new regulatory molecules. Our understanding of how lncRNA s regulate biological functions and their importance to disease aetiology, while still limited, is rapidly improving, in particular with regards to their role in cancer. Herein we review the identification of several lncRNAs shown to impact on melanoma disease progression and discuss how these molecules are operating at the molecular level.

KW - Long non-coding RNA

KW - Melanoma

KW - Metastasis

UR - http://www.scopus.com/inward/record.url?scp=84907701046&partnerID=8YFLogxK

U2 - 10.3892/ijo.2014.2691

DO - 10.3892/ijo.2014.2691

M3 - Review article

VL - 45

SP - 2181

EP - 2186

JO - International Journal of Oncology

JF - International Journal of Oncology

SN - 1019-6439

IS - 6

ER -